Harvard Bioscience (HBIO) vs Standard BioTools (LAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Standard BioTools (LAB) over the past year, gaining 93.2% versus a loss of 47.8%. Over five years, LAB leads with a -87.3% price change compared with -87.6% for HBIO. Standard BioTools is the larger company by market cap ($266.4 million vs $38.7 million), about 6.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HBIO | LAB |
|---|---|---|
| Share price | $8.50 | $0.6787 |
| Market cap | $38.69M | $266.44M |
| 1-day change | -0.70% | -6.00% |
| YTD return | +26.87% | -46.98% |
| 1-year return | +93.18% | -47.79% |
| 5-year return | -87.57% | -87.29% |
| Forward P/E | 13.18 | — |
| EPS (TTM) | $-2.31 | $-0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.40 | $1.72 |
| 52-week low | $3.80 | $0.63 |
| Distance from 52-week high | -9.57% | -60.54% |
| Average volume | 18.02K | 1.57M |
| Shares outstanding | 4.55M | 392.58M |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Standard BioTools is about 6.9 times larger than Harvard Bioscience by market value ($266.44M vs $38.69M).
- HBIO has outperformed LAB by 141.0 percentage points over the past year.
HBIO vs LAB FAQ
Which is bigger, Harvard Bioscience or Standard BioTools?
Standard BioTools (LAB) is larger, with a market capitalization of $266.44M compared with $38.69M for Harvard Bioscience (HBIO).
Which stock has performed better over the past year, HBIO or LAB?
HBIO returned +93.18% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Harvard Bioscience and Standard BioTools in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.